Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.03644
0.00 (0.00%)
May 26, 2026, 9:30 AM EST

RMTG Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-7.81-5.56-9.81-5.51-12.88
Depreciation & Amortization
0.280.220.310.150.04
Other Amortization
1.372.133.061.760.89
Asset Writedown & Restructuring Costs
--4.13--
Stock-Based Compensation
0.02-00.010.28
Other Operating Activities
-0.50-1.52-0.080.26
Change in Accounts Receivable
-0.0200.03-0.03-0
Change in Inventory
-0.15-0.01---
Change in Accounts Payable
6.154.13.412.521.31
Change in Other Net Operating Assets
-0.04-0.03-0.02-0.24
Operating Cash Flow
-0.710.85-0.42-1.11-9.88
Capital Expenditures
-0.6-0.22-0.39-0.2-
Cash Acquisitions
----0.67
Investing Cash Flow
-0.6-0.22-0.39-0.20.67
Long-Term Debt Issued
1.1---12.4
Total Debt Issued
1.1---12.4
Long-Term Debt Repaid
---0.01-0.02-0.25
Total Debt Repaid
---0.01-0.02-0.25
Net Debt Issued (Repaid)
1.1--0.01-0.0212.15
Other Financing Activities
---0.3--
Financing Cash Flow
1.1--0.31-0.0212.15
Net Cash Flow
-0.210.64-1.11-1.332.94
Free Cash Flow
-1.310.64-0.8-1.31-9.88
Free Cash Flow Margin
-25.67%15.47%-33.40%-85.78%-2255.99%
Free Cash Flow Per Share
-0.100.05-0.07-0.11-0.86
Cash Interest Paid
--000
Levered Free Cash Flow
4.252.760.590.57-4.74
Unlevered Free Cash Flow
7.544.161.591.56-3.93
Change in Working Capital
5.944.063.422.491.55
Source: S&P Global Market Intelligence. Standard template. Financial Sources.